Abstract
The term “fluorescence” was first proposed nearly two centuries ago, yet its application in Medicine
has a relatively brief history of only 70 years. Nowadays, as fluorescence was gradually approaching
into more medicine studies, fluorescence image-guided surgery has become the new arena for this
technology. It allows surgeons to real-time visualize the target structure intraoperatively to increase
the efficacy of surgical tissue resection and meanwhile avoid unnecessary radical treatment during
open surgery, laparoscopy, thoracoscopy, or endoscopes. In this review, we introduce the concept of
near-infrared fluorescence imaging for cancer surgery, review the clinical trial literature to date,
outline the key issues pertaining to imaging system and contrast agent optimization, discuss
limitations and leverage, and provide a framework for making the technology available for the routine
care of cancer patients in the near future.